FIELD: medicine.
SUBSTANCE: invention relates to use of activated carbon fibres as an adsorbent toxin level when administered orally. Invention relates to activated carbon fibre-containing adsorbent for oral administration for treating or preventing renal diseases or complications dialysis.
EFFECT: treatment or prevention of renal diseases or complications of dialysis.
7 cl, 4 dwg, 5 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396964C2 |
ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396965C2 |
ORALLY ADMINISTRATED ADSORBENT, THERAPEUTIC AGENT FOR KIDNEY DISEASE AND THERAPEUTIC AGENT FOR LIVER DISEASE | 2014 |
|
RU2632432C2 |
ADSORBENT FOR PERORAL ADMINISTRATION AND AGENT FOR TREATMENT OR PREVENTION OF KIDNEY OR LIVER DISEASES | 2003 |
|
RU2292211C2 |
ADSORBENT FOR PERORAL ADMINISTRATION | 2003 |
|
RU2306941C2 |
METHOD OF PRODUCING ADSORBENT BASED ON ACTIVATED CARBON | 2020 |
|
RU2811471C2 |
MEDICAL ADSORBENT AND METHOD FOR ITS OBTAINING | 2011 |
|
RU2627464C2 |
METHOD OF PRODUCING SPHERICAL ACTIVATED CARBON | 2005 |
|
RU2375302C2 |
ADSORBENT, CLEANER, MEDICATION IN CASE OF RENAL FAILURE AND FUNCTIONAL NUTRITION | 2009 |
|
RU2478393C2 |
AGENT FOR ELIMINATION OF CIRCULAR DYSFUNCTION FACTOR | 2005 |
|
RU2362570C2 |
Authors
Dates
2016-05-10—Published
2012-10-05—Filed